SpectraCure AB (publ) (STO:SPEC)
Sweden · Delayed Price · Currency is SEK 0.0237
-0.0002 (-0.84%)
Sep 4, 2026, 5:23 PM CET
SpectraCure AB Revenue
SpectraCure AB had revenue of 210.00K SEK in the quarter ending June 30, 2026, a decrease of -40.34%. This brings the company's revenue in the last twelve months to 627.00K, down -48.05% year-over-year. In the year 2025, SpectraCure AB had annual revenue of 868.00K, down -43.31%.
Revenue (ttm)
627.00K
Revenue Growth
-48.05%
P/S Ratio
-55.88
Revenue / Employee
-18.62K
Employees
13
Market Cap
13.52M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 868.00K | -663.00K | -43.31% |
| Dec 31, 2024 | 1.53M | -1.31M | -46.15% |
| Dec 31, 2023 | 2.84M | -98.00K | -3.33% |
| Dec 31, 2022 | 2.94M | -2.81M | -48.84% |
| Dec 31, 2021 | 5.75M | 616.00K | 12.00% |
| Dec 31, 2020 | 5.13M | 1.89M | 58.04% |
| Dec 31, 2019 | 3.25M | -479.57K | -12.87% |
| Dec 31, 2017 | 3.73M | 281.21K | 8.16% |
| Dec 31, 2016 | 3.45M | 2.37M | 220.37% |
| Dec 31, 2015 | 1.08M | -135.64K | -11.20% |
| Dec 31, 2014 | 1.21M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Boule Diagnostics AB | 461.29M |
| Arcoma AB | 127.27M |
| ScandiDos AB | 54.22M |
| Promimic AB | 47.07M |
| Nosa Plugs AB | 31.84M |
| Perpetua Medical AB | 19.58M |
| Clinical Laserthermia Systems AB | 12.56M |
| Luxbright AB | 8.96M |
SpectraCure AB News
- 15 days ago - SpectraCure AB Quarterly report: Q2 2026 - Filings
- 3 months ago - SpectraCure AB Quarterly report: Q1 2026 - Filings
- 6 months ago - SpectraCure AB Quarterly report: Q4 2025 - Filings
- 6 months ago - SpectraCure AB Annual report: Q4 2025 - Filings
- 9 months ago - SpectraCure AB Quarterly report: Q3 2025 - Filings